Luteolin attenuates acute liver allograft rejection in rats by inhibiting T cell proliferation and regulating T cell subsets
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110407 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Hao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Transplantation, The Second Xiang-ya Hospital, Central South University, Changsha, Hunan 410011, China; The First Central Clinica…. Hauptthemen laut MEDLINE: Luteolin, Liver Transplantation, Graft Rejection, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Project of Research and Development Plan of Hunan Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Allograft rejection continues to be a significant cause of morbidity and graft failure for liver transplant recipients. Existing immunosuppressive regimens have many drawbacks, thus safe and effective long-term immunosuppressive regimens are still required. Luteolin (LUT), a natural component found in many plants, has a variety of biological and pharmacological effects and shows good anti-inflammatory activity in inflammatory and autoimmune diseases. Nevertheless, it remains unclear how it affects acute organ rejection after allogeneic transplantation. In this study, a rat liver transplantation model was constructed to investigate the effect of LUT on acute rejection of organ allografts. We found that LUT significantly protected the structure and function of liver grafts, prolonged recipient rat survival, ameliorated T cell infiltration, and downregulated proinflammatory cytokines. Moreover, LUT inhibited the proliferation of CD4+ T cells and Th cell differentiation but increased the proportion of Tregs, which is the key to its immunosuppressive effect. In vitro, LUT also significantly inhibited CD4+ T cell proliferation and Th1 differentiation. There may be important implications for improving immunosuppressive regimens for organ transplantation as a result of this discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Transplantation, The Second Xiang-ya Hospital, Central South University, Changsha, Hunan 410011, China; The First Central Clinical School, Tianjin Medical University, Tianjin 300190, China.
- Department of Liver Transplantation, The Second Xiang-ya Hospital, Central South University, Changsha, Hunan 410011, China; Transplant Medical Research Center, The Second Xiang-ya Hospital, Central South University, Cha…
Förderung
- Key Project of Research and Development Plan of Hunan Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wang, H., Li, C., Xiong, Z., & Li, T. (2023). Luteolin attenuates acute liver allograft rejection in rats by inhibiting T cell proliferation and regulating T cell subsets. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110407
Vancouver
Wang H, Li C, Xiong Z, Li T. Luteolin attenuates acute liver allograft rejection in rats by inhibiting T cell proliferation and regulating T cell subsets. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110407
BibTeX
@article{Wang2023,
author = {Wang, Hao and Li, Chenxuan and Xiong, Zhiwei and Li, Ting},
title = {Luteolin attenuates acute liver allograft rejection in rats by inhibiting T cell proliferation and regulating T cell subsets},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110407}
}
EUVIMED